Italian Cohort of Antiretroviral-Naive Patients (ICONA)
ICONA investigates treatment outcomes in an Italian population of Human Immunodeficiency Virus (HIV) positive adults. The cohort recruited adults aged 18 or older who had tested positive for HIV and never received antiretroviral therapy from across Italy, encompassing a diverse group of the Italian HIV-positive population. Since its inception in 1997, the cohort continually enrolled new participants, reaching over 20,000 participants by 2023, to enhance the understanding of HIV treatment outcomes. Follow-ups were conducted every 4-6 months to monitor the participants’ health and treatment progress.
Study design
Cohort - clinical
Number of participants at first data collection
20,500 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
1997
Primary Institutions
ICONA Foundation (Fondazione ICONA)
Profile paper DOI
Funders
Janssen-Cilag
Abbott
Bristol-Myers Squibb (BMS)
Gilead Sciences
GlaxoSmithKline (GSK)
Ongoing?
No
Data types collected
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-report questionnaire – unspecified
- None
- None
- None
Engagement
Keywords
Consortia and dataset groups
